Avenue Therapeutics, Inc.
ATXI
$0.28
-$0.03-8.35%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | 0.00 | -- | 1.40M | -- |
| Total Revenue | -- | 0.00 | -- | 1.40M | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | 0.00 | -- | 1.40M | -- |
| SG&A Expenses | 514.00K | 698.00K | 547.00K | 915.00K | 1.49M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 714.00K | 955.00K | 724.00K | 1.11M | 1.91M |
| Operating Income | -714.00K | -955.00K | -724.00K | 297.00K | -1.91M |
| Income Before Tax | -695.00K | -726.00K | -692.00K | 329.00K | -1.86M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -695.00K | -726.00K | -692.00K | 329.00K | -1.86M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 17.00K | 9.00K | 6.00K | 6.00K |
| Net Income | -695.00K | -709.00K | -683.00K | 335.00K | -1.85M |
| EBIT | -714.00K | -955.00K | -724.00K | 297.00K | -1.91M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.21 | -0.22 | -0.21 | 0.11 | -0.62 |
| Normalized Basic EPS | -0.13 | -0.18 | -0.13 | 0.07 | -0.39 |
| EPS Diluted | -0.21 | -0.22 | -0.21 | 0.11 | -0.62 |
| Normalized Diluted EPS | -0.13 | -0.18 | -0.13 | 0.07 | -0.39 |
| Average Basic Shares Outstanding | 3.29M | 3.18M | 3.18M | 3.18M | 2.97M |
| Average Diluted Shares Outstanding | 3.29M | 3.18M | 3.18M | 3.18M | 2.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |